Publications by authors named "Liwang Lin"

Claim this Profile
I
Involvement of TMAO in exacerbating arsenic-induced neurotoxicity by activating the PERK/eIF2α/ATF4 pathway.
Hong Zhang, Kai Ren, Xiaoting Ni, Liwang Lin, Longyu Li

Ecotoxicol Environ Saf· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
Chunlu Gao, Liwang Lin, Jing Li, Mengliang Wu, Jian Lv

Toxicol Lett· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.
Haitao Li, Chunlu Gao, Liwang Lin, Gensheng Zhang, Shengjin Fan

J Clin Pharm Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro.
Zhiqiang Wu, Hongzhu Chen, Liwang Lin, Jing Lu, Qilei Zhao

Toxicol Res (Camb)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
Meihua Guo, Qilei Zhao, Shengjin Fan, Zhiqiang Wu, Liwang Lin

Br J Clin Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
Sixun Guo, Xinyu Wang, Chunlu Gao, Zhiqiang Wu, Hongzhu Chen, Liwang Lin

Toxicol Lett· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.
Xinyu Wang, Zhao Qian, Haitao Li, Hongzhu Chen, Liwang Lin

J Pharm Biomed Anal· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
Qilei Zhao, Meihua Guo, Thomas H Hostetter, Hongzhu Chen, Liwang Lin

Expert Rev Clin Pharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Characteristics, Tissue Bioaccumulation and Toxicity Profiles of Oral Arsenic Trioxide in Rats: Implications for the Treatment and Risk Assessment of Acute Promyelocytic Leukemia.
Wensheng Liu, Bin Wang, Yilei Zhao, Zhiqiang Wu, Andi Dong, Liwang Lin

Front Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
Meihua Guo, Jin Zhou, Shengjin Fan, Limin Li, Hongzhu Chen, Liwang Lin

Expert Rev Clin Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis